Skip to main content

Table 1 Clinical characteristics of subjects participating in study I and II

From: Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation

 

Study I

Study II

Healthy (n = 5)

Controla (n = 14)

Asthma + CRS (n = 15)

Asthma only (n = 13)

Sex (M/F)

0/5

5/9

4/11

3/10

Age (years)

41 ± 7

40 ± 3

38 ± 3

44 ± 3

Body mass index

25.2 ± 1.2

24.4 ± 0.5

25.5 ± 0.9

27.4 ± 1.4

FEV1 (% predicted)

111 ± 6

101 ± 4

96 ± 4

93 ± 4

FeNO (ppb)

12 ± 1

15 ± 2

15 ± 5

19 ± 3

SPT (neg/pos)

3/1b

10/3b

4/11

2/11

  1. Where appropriate, data are expressed as mean ± SEM
  2. All subject included had withdrawn from antihistamines for 72 h, long acting beta agonist (LABA) for 24 h and short acting beta agonist (SABA) for 8 h and Spiriva for 24 h prior to sample collection
  3. M male; F female; FEV 1 forced expiratory volume in 1 s; FeNO fractional exhaled nitric oxide; SPT skin prick test
  4. aThe subjects in study I are also included in study II as controls
  5. bOne value missing
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us